Sentence examples for methodological concerns to from inspiring English sources

They described some methodological concerns to be considered when designing automatic systems for pathological voice detection.

This paper describes some methodological concerns to be considered when designing systems for automatic detection of voice pathology, in order to enable comparisons to be made with previous or future experiments.

Despite these methodological concerns, to our knowledge, this was the first study to review the epidemiology of depression among Chinese CKD patients who were not treated by dialysis, a fact which can be useful in developing an early therapeutic regimen for Asian CKD patients.

The most important methodological concern to stress about scales designed to measure a latent construct is that they are not solely a collection of questions of interest to the researcher.

The research in brain plasticity is used to explore methodological concerns peculiar to neuroscience.

Head to head trials have been proposed as an alternative to the ethical and methodological concerns related to placebo-controlled trials.

The review intends to identify its major contributions and key methodological concerns related to the use of think-aloud protocol in self-regulated reading research.

For observational studies, the framework for inclusion in guidelines is not similarly well-developed and there are methodological concerns specific to screening interventions, such as small effects in absolute terms.

First, because the measurement of non-cognitive skills has been traditionally based on self-reports which raises several methodological concerns due to misreports, difficulties in interpersonal comparisons or the socially desirable response bias (see King et al. 2004; Paulhus 1984; Soest et al. 2011).

Although the interpretation of these trials is complicated by heterogeneity in study design, small patient numbers and methodological concerns related to appropriate selection and blinding of patients, the results of ongoing larger phase II/III trials should soon be available to determine if these agents will be useful additions to the cardiovascular armamentarium.

Collectively, these modifications in step 1b allow for the requisite assembly of evidence of projected harms and consideration of a host of associated methodological concerns related to institutional adaptive capacity (e.g., Gosling et al. 2012; Huang et al. 2011).